Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

510(k) clearance for Picker's ACQPLAN :

This article was originally published in Clinica

Executive Summary

The FDA has cleared Picker International's ACQPLAN three dimensional radiation therapy planning (RTP) system for marketing in the US. The device calculates treatment dose in monitor units and can also be used with the company's ACQSIM CT simulator, eliminating the need to transfer CT simulation images to remote RTP workstations. With the integrated ACQPLAN/ACQSIM system, the patient only needs to be scanned for around two minutes, long enough to acquire basic datasets. The whole simulation and three-dimensional RTP process is then carried out using this "virtual" CT data. This method increases patient's comfort as well as CT scanner throughput hence reduces costs, said Picker.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT082070

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel